SARS-CoV-2 Spike Glycoprotein B.1.1.529-Omicron
SARS-CoV-2 Spike Glycoprotein B.1.1.529-Omicron
Description
| Source |
Severe Acute Respiratory Syndrome-related coronavirus 2 (Spike B.1.1.529) Spike glycoprotein (covering the following mutations: A67V, H69-, V70-, T95I, G142-, V143-, Y144-, Y145D, N211-, L212I, “EPE” insertion between 214R and 215D, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F). |
| Gene ID |
S |
| Length |
1270 aa |
| Purity |
Crude (Major peak by ESI-MS is guaranteed to be peptide of interest – determined at 220 nm for each individual peptide). |
| Solubility |
Dissolve in a minimum amount of pure DMSO (approx. 40 µl) and dilute with PBS buffer to the final concentration. Please note that the final concentration of DMSO must be below 1 % (v/v) to avoid toxicity in the biological system. |
| Form |
Lyophilized |
| Storage |
Store at -20°C. |
| Note |
The peptides of this product are supplied as trifluoroacetate salts. |
Reviews
There are no reviews yet.